Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.33 USD | -2.01% | -3.06% | +2.26% |
Apr. 19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
Apr. 01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.26% | 193M | |
+25.61% | 660B | |
+22.72% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.77% | 219B | |
-9.69% | 196B | |
+6.41% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- LFCR Stock
- News Lifecore Biomedical, Inc.
- Landec : Roth Capital Adjusts Landec PT to $12 From $15, Maintains Buy Rating